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Abstract. 
 
b
 
-Catenin plays a pivotal role in the tran-
scriptional activation of Wnt-responsive genes by bind-
ing to TCF/LEF transcription factors. Although it has 
been suggested that the COOH-terminal region of
 
b
 
-catenin functions as an activation domain, the
mechanisms of activation remain unclear. To screen for 
potential transcriptional coactivators that bind to the 
COOH-terminal region of 
 
b
 
-catenin, we used a novel 
yeast two-hybrid system, the Ras recruitment system 
(RRS) that detects protein–protein interactions at the 
inner surface of the plasma membrane. Using this sys-
tem, we isolated the CREB-binding protein (CBP). Ar-
madillo (Arm) repeat 10 to the COOH terminus of
 
b
 
-catenin is involved in binding to CBP, whereas
 
b
 
-catenin interacts directly with the CREB-binding do-
main of CBP. 
 
b
 
-Catenin synergizes with CBP to stimu-
late the activity of a synthetic reporter in vivo. Con-
versely, 
 
b
 
-catenin–dependent transcriptional activation 
is repressed by E1A, an antagonist of CBP function, 
but not by an E1A mutant that does not bind to CBP. 
 
The activation of Wnt target genes such as 
 
siamois
 
 and 
 
Xnr3
 
 in 
 
Xenopus
 
 embryos is also sensitive to E1A. 
These ﬁndings suggest that CBP provides a link be-
tween 
 
b
 
-catenin and the transcriptional machinery, and 
possibly mediates the oncogenic function of 
 
b
 
-catenin.
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Introduction
 
Wnt signaling pathways regulate a variety of processes in-
cluding cell growth, oncogenesis, and development (Moon
et al., 1997; Miller et al., 1999). Upon Wnt signaling, 
 
b
 
-cat-
enin accumulates in the nucleus, and binds to transcription
factors of the TCF/LEF
 
1
 
 family, leading to transcriptional
activation (Behrens et al., 1996). The TCF/LEF family
members contain a single DNA-binding high mobility
group (HMG) domain, whereas 
 
b
 
-catenin provides trans-
activation domains (reviewed by Barker et al., 2000). In
the absence of nuclear 
 
b
 
-catenin, the TCF/LEF transcrip-
tion factors recruit the Groucho and CtBP corepressors to
repress transcription (Roose et al., 1998; Brannon et al.,
1999). An additional corepressor protein, the 
 
Drosophila
melanogaster 
 
CREB-binding protein (dCBP), was shown
to be involved in the repression of dTCF target genes in
vivo (Waltzer and Bienz, 1998). In response to Wnt signal-
ing, 
 
b
 
-catenin somehow overcomes these repressive ef-
fects to activate transcription. Constitutive activation of
downstream target genes, such as c-
 
myc
 
 and 
 
cyclin D1
 
 by
the TCF/LEF-
 
b
 
-catenin complex is implicated in the de-
velopment of cancer (He et al., 1998; Tetsu and McCor-
mick, 1999).
 
b
 
-Catenin and its 
 
Drosophila
 
 ortholog, Armadillo
(Arm), are composed of 12 Arm repeats flanked by
unique NH
 
2
 
 and COOH termini. Based on reporter gene
assays, it has been suggested that two regions of 
 
b
 
-catenin
mediate transcriptional activation (Hsu et al., 1998; Hecht
et al., 1999). In particular, the COOH-terminal activation
domain was reported to be sufficient both for signaling
and for oncogenic transformation (reviewed by Hecht et
al., 1999). Genetic analysis has also demonstrated that the
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Abbreviations used in this paper
 
: Arm, Armadillo; CBP, CREB-bind-
ing protein; CREB, cAMP-response element binding protein; GST, glu-
tathione S
 
-
 
transferase; LEF, lymphoid enhancer factor; pt, point-mutant;
RRS, Ras recruitment system; RT-PCR, reverse transcriptase PCR; TCF,
T cell factor.
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corresponding region of Arm is required for Wingless sig-
naling in vivo (Cox et al., 1999). However, the underlying
mechanisms for transcriptional activation by 
 
b
 
-catenin are
poorly understood.
In the present study, we have identified CBP as a tran-
scriptional coactivator that binds to the COOH-terminal
region of 
 
b
 
-catenin. 
 
b
 
-Catenin physically interacts with the
CREB-binding domain of CBP. CBP then cooperates with
 
b
 
-catenin to activate transcription in mammalian cells and
 
Xenopus laevis 
 
embryos.
 
Materials and Methods
 
Plasmids
 
An expression plasmid, pRas(61)
 
D
 
F-
 
b
 
catR8-C, encoding the RRS bait
was constructed by inserting cDNA sequences encompassing COOH-ter-
minal region of 
 
Xenopus
 
 
 
b
 
-catenin (amino acids 425–781) in frame with
activated Q61L c-Ha-Ras into the 3S0B-SRS (Isakoff et al., 1998). The
mouse CBP expression plasmid pRc/RSV-mCBP-HA and GST-CBP 451–
682 fusion plasmid were gifts from R. Goodman (Vollum Institute, Port-
land, OR; Chrivia et al., 1993; Kwok et al., 1996). Expression plasmids for
E1A, E1A mutRB, and E1A mutCBP were provided by T. Kouzarides
(Wellcome/CRC Institute, Cambridge, UK; Bannister and Kouzarides,
1995). dnLEF-1 expression plasmid was a gift from J. Behrens (Max Del-
bruck Center, Berlin, Germany; Behrens et al., 1996). The 
 
b
 
-catenin dele-
tion constructs shown in Fig. 1 B were amplified by PCR, digested with
BamHI, and subcloned into the BamHI site of 3S0B-SRS. To generate
His-tagged 
 
b
 
catR10-C expression plasmid and GAL4-
 
b
 
catR10-C fusion
construct, an insert of the corresponding yeast expression plasmid was ex-
cised, and subcloned into pET-28c (Novagen) and pCMV-BD (Strat-
agene), respectively. GAL4 reporter plasmid pFR-Luc was obtained from
Stratagene. For in vitro synthesis of RNA used in 
 
Xenopus
 
 injection ex-
periments, the full-length mouse CBP cDNA from pRc/RSV-mCBP-HA
was inserted into the HindIII and SacI sites of pXeX (Johnson and Krieg,
 
1994). An EcoRI fragment encoding E1A or E1A mutCBP was subcloned
into pCS2
 
1
 
.
 
RRS Screening
 
RRS screening in yeast was performed as described (Broder et al., 1998).
In brief, 
 
cdc25-2
 
 cells were first cotransformed with the pRAS(61)
 
D
 
F-
 
b
 
catR8-C bait and mGAP expression plasmid (Aronheim, 1997), and then
used to transform with HeLa cell cDNA library. The expression of library
cDNA was controlled by a galactose-inducible promoter. Transformants
were grown on selectable minimal glucose plates for 5 d at 25
 
8
 
C, followed
by replica plating onto minimal galactose plates, and incubated at 37
 
8
 
C for
5–7 d. Positive colonies exhibiting efficient growth on galactose plates at
37
 
8
 
C were isolated and tested for galactose-dependent growth at 37
 
8
 
C. Li-
brary plasmids were extracted and further analyzed by DNA sequencing
and retransformation of 
 
cdc25-2
 
 cells to test the specificity of interaction.
 
In Vitro Binding Assays
 
2 
 
m
 
g of GST or GST-CBP 451-682 was incubated with 1 
 
m
 
g of bacterially
expressed and purified His-tagged 
 
b
 
catR10-C or c-
 
myc
 
 epitope-tagged
 
b
 
-catenin (Yost et al., 1996) at 4
 
8
 
C for 1 h in 20 
 
m
 
l of protein-binding
buffer (PBB; 20 mM Hepes-NaCl, pH 7.9, 20% glycerol, 0.5 mM EDTA,
60 mM NaCl, 6 mM MgCl
 
2
 
, 0.1% NP-40, 5 mM 2-mercaptoethanol, 1 mM
PMSF). After incubation, 2 
 
m
 
l of glutathione-Sepharose 4B (Pharmacia
Biotech) in 20 
 
m
 
l of PBB was added, and the mixture was rotated at 4
 
8
 
C
for 1 h. The beads were collected and washed with PBB, and then bound
proteins were eluted for SDS-PAGE. His-tagged 
 
b
 
catR10-C and 
 
b
 
-cate-
nin were detected on immunoblots by an anti-His antibody (Qiagen) and
an anti-
 
myc
 
 antibody, respectively.
 
Cell Culture, Coimmunoprecipitation, and
Luciferase Assays
 
HeLa and COS7 cells were maintained in MEM and DME with 10%
FBS, respectively. SW480 cells were maintained in Opti-MEM I (GIBCO
BRL) supplemented with 10% FBS. Transient transfections into HeLa
cells were carried out by the calcium phosphate precipitation method.
Figure 1. Interaction be-
tween  b-catenin and CBP. A,
Complementation of the
cdc25-2 mutation through
the interaction of b-catenin
COOH-terminal region with
CBP. The temperature-sensi-
tive cdc25-2 yeast cells were
cotransformed with the indi-
cated plasmids and the CBP
expression plasmid isolated
in the screening, and incu-
bated on galactose contain-
ing plates either at 25 (left)
or 378C (right). B, Fine map-
ping of the b-catenin domain
that binds to CBP in yeast.
Cells were cotransformed
with the indicated plasmids
together with the CBP ex-
pression plasmid, and tested
for the growth at 378C as de-
scribed for A. The numbers indicate the locations in the amino acid sequence of b-catenin. 11, Efficient growth; 1, poor growth; 2, no
growth. C, b-Catenin directly binds to CREB-binding domain of CBP. Bacterially expressed and purified His-tagged bcatR10-C or
myc-tagged b-catenin was incubated with buffer (lane 5), GST (lanes 2 and 6), or GST-CBP 451–682 (lanes 3 and 7). After extensive
washing, bound proteins were eluted and resolved by SDS-PAGE. bCatR10-C and b-catenin were detected by an anti-His antibody and
an anti-myc antibody, respectively. Approximately 10% of the input is shown (lanes 1 and 4). D, Coimmunoprecipitation of CBP and
b-catenin. COS7 cells were transfected with expression plasmids for CBP and/or myc-tagged pt b-catenin as indicated. Cell lysates were
immunoprecipitated with anti-CBP polyclonal antibodies 2 d after transfection. The immunoprecipitates were separated by SDS-
PAGE and subjected to Western blotting with anti-myc antibodies.
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SW480 and COS7 cells were transfected using lipofectamine Plus
(GIBCO BRL). For coimmunoprecipitation experiments, COS7 cells
were transfected with 0.5 
 
m
 
g of 
 
myc
 
-tagged point-mutant (pt) 
 
b
 
-catenin
expression plasmid (Yost et al., 1996) and/or 1 
 
m
 
g of pRc/RSV-CBP-HA.
Two days later, cells were washed and lysed in 1 ml of a lysis buffer (20
mM Tris-HCl, pH 8.0, 75 mM NaCl, 1.5 mM MgCl
 
2
 
, 1 mM EGTA, 0.5%
NP-40, 10% glycerol, 1 mM PMSF, 10 
 
m
 
g/ml each of leupeptin and aproti-
nin). Cell lysates were cleared and incubated with anti-CBP polyclonal an-
tibodies (A-22; Santa Cruz Biotechnology), followed by incubation with
protein A–Sepharose beads (Sigma Chemical Co.). The beads were col-
lected and washed three times with the lysis buffer before SDS 8%
PAGE. Immunoblotting was subsequently performed with an anti-
 
myc
 
mAb. For luciferase assays, a 
 
b
 
-galactosidase expression plasmid was in-
cluded in each transfection as an internal control. Luciferase and 
 
b
 
-galac-
tosidase activities were measured 24 h after transfection, and luciferase ac-
tivity was normalized to 
 
b
 
-galactosidase activity. Each transfection was
performed in triplicate and repeated at least three times.
 
RNA Injections and Reverse Transcriptase
PCR Analysis
 
RNA injections and RT-PCR analysis were carried out as described previ-
ously (Brannon et al., 1999).
 
Results and Discussion
 
To identify proteins that interact with the COOH-terminal
region of 
 
b
 
-catenin and that might be involved in tran-
scriptional activation, we carried out an extensive screen-
ing using the RRS. Conventional yeast two-hybrid system
was not suitable for our purpose because this region of
 
b
 
-catenin activates the reporter expression by itself when
fused to a heterologous DNA-binding domain in yeast
(Hecht et al., 1999). RRS is based on the ability of mam-
malian Ras to rescue the growth defect of the yeast tem-
perature-sensitive 
 
cdc25-2
 
 strain, in which the endogenous
Ras is inactive at the nonpermissive temperature (37
 
8
 
C)
due to the lack of a functional Cdc25 guanyl nucleotide ex-
change factor (Broder et al., 1998). For RRS screening, a
bait protein of interest is fused at the COOH terminus of
mammalian activated Ras lacking its membrane localiza-
tion signal [Ras(61)
 
D
 
F], whereas library cDNAs are fused
to the v-Src myristoylation sequence targeted to the
plasma membrane. A protein–protein interaction between
the bait and library protein results in the recruitment of
Ras to the membrane and complementation of the 
 
cdc25-2
 
mutation.
We used the COOH-terminal region of 
 
Xenopus
 
 
 
b
 
-cate-
nin extending from Arm repeat 8 to the COOH terminus,
 
b
 
catR8-C (Fig. 1 B), as a bait to cotransform 
 
cdc25-2
 
 yeast
cells with a myristoylated HeLa cell cDNA library. After
screening 
 
z
 
2.5 
 
3
 
 10
 
6
 
 colonies, a single clone encoding an
NH
 
2
 
-terminal fragment of CBP (amino acids 153–822) was
isolated. To confirm the specificity of the interaction, the
plasmid encoding CBP was recovered, and retransformed
into the same yeast strain with either an expression plas-
mid for Ras(61)
 
D
 
F-
 
b
 
catR8-C or a negative control plas-
mid encoding Ras(61)
 
D
 
F alone. As shown in Fig. 1 A,
 
cdc25-2
 
 cells transformed with the CBP expression plas-
mid were able to grow at 37
 
8
 
C when coexpressed with
Ras(61)DF-bcatR8-C, but not with Ras(61)DF, suggesting
that the interaction is dependent on the bcatR8-C bait.
To further narrow down the CBP interaction domain in
b-catenin, a series of Ras(61)DF-b-catenin fusion con-
structs spanning the COOH-terminal region were trans-
formed into cdc25-2 cells, together with the CBP expres-
sion plasmid, and tested for growth at 378C (Fig. 1 B).
Although Arm repeats 8 and 9 are dispensable, deletion to
Arm repeat 11 diminished the interaction with CBP. No
interaction was seen with Arm repeats 8–12 or the COOH
terminus alone. Western blot experiments with anti-Ras
mAbs verified that all the b-catenin fusion proteins were
expressed at similar levels in yeast (data not shown).
Taken together, these results show that Arm repeat 10 to
the COOH terminus of b-catenin is involved in the inter-
action with CBP.
The CBP clone isolated in our screening contains a
CREB-binding domain, also called the KIX domain
(Parker et al., 1996). This domain has been demonstrated
to contact a large number of transcription factors such as
CREB, c-Jun, Tax, and c-Myb (reviewed by Goldman et
al., 1997). To investigate whether the CREB-binding do-
main of CBP could bind to b-catenin, GST pull-down as-
says were performed (Fig. 1 C). We found that a GST fu-
sion protein with the CREB-binding domain of CBP
(amino acids 451–682) was able to bind to Arm repeat 10
to the COOH terminus of b-catenin (Fig. 1 C, lane 3), as
well as full-length b-catenin (Fig. 1 C, lane 7). The binding
was specific because neither bcatR10-C nor full-length
b-catenin showed any interaction with GST alone (Fig. 1
C, lanes 2 and 6). These data demonstrate that b-catenin
directly binds to the CREB-binding domain of CBP.
We next examined whether b-catenin and CBP would
interact in vivo by coimmunoprecipitation experiments.
CBP and myc-tagged pt b-catenin were expressed either
individually or in combination in COS7 cells. Cell lysates
from each culture were immunoprecipitated with anti-
CBP antibodies, and immunoblotted with anti-myc anti-
bodies. As shown in Fig. 1 D, b-catenin coimmunoprecipi-
tates with CBP (Fig. 1 D, lane 3). Thus, we conclude that
b-catenin and CBP exist as a complex in vivo.
CBP and the closely related homologue p300 are known
to function as transcriptional coactivators by connecting a
Figure 2. CBP synergizes with b-catenin to activate transcription.
HeLa cells were transiently transfected with 1 mg of pTOP-
FLASH or pFOPFLASH reporter, indicated amounts of CBP
expression plasmid, either with or without 1 mg of pt b-catenin–
encoding plasmid. Transfections were carried out in triplicate
and the means 6 SD are shown. Where they are not evident, this
is due to minimal variability between transfections.
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variety of transcription factors to the basal transcription
machinery (reviewed by Goldman et al., 1997). Addition-
ally, CBP/p300 possesses histone acetyltransferase activ-
ity, suggesting that it potentiates transcription by loosen-
ing the chromatin structure (Ogryzko et al., 1996). On the
other hand, in Drosophila dCBP acetylates dTCF in the
Arm-binding domain, and lowers the affinity of dTCF for
Arm, thereby negatively regulating Wingless signaling
(Waltzer and Bienz, 1998). In an attempt to evaluate the
physiological significance of the interaction between CBP
and  b-catenin, we performed transient transfections in
HeLa cells with the TCF reporter plasmid pTOPFLASH
containing three optimal TCF binding sites, or the mutant
negative control plasmid pFOPFLASH (Korinek et al.,
1997). A stabilized b-catenin was used in which four serine
and threonine residues at NH2 terminus were changed to
alanine (pt b-catenin; Yost et al., 1996). Fig. 2 shows that
expression of pt b-catenin resulted in about a threefold in-
crease in luciferase activity compared with pTOPFLASH
alone. The level of b-catenin was saturated under this con-
dition since we did not observe a further increase in lu-
ciferase activity with a larger amount of pt b-catenin
expression plasmid (data not shown). The b-catenin–
dependent transcription was further activated by co-
transfecting a vector expressing CBP in a dose-dependent
manner, more than doubling the activity observed with
saturating levels of b-catenin alone (Fig. 2). Similarly, the
activation by wild-type b-catenin was also stimulated by
CBP (data not shown). These data are consistent with the
observation that the amount of CBP in cells is limiting
(Kwok et al., 1994). In contrast, minimal stimulation by
CBP was observed in the absence of b-catenin (Fig. 2). In
separate experiments using human embryonic kidney 293
cells, we also observed that when we had reached saturat-
ing levels of b-catenin, and then cotransfected CBP, there
was a greater than doubling of the luciferase activity (data
not shown). As expected, the synergistic activation by
b-catenin and CBP was not observed with the control
pFOPFLASH (Fig. 2). These functional assays clearly in-
dicate that CBP acts as a coactivator for b-catenin in mam-
malian cells.
The adenovirus E1A oncoprotein is known to bind and
inhibit the function of CBP (reviewed by Goldman et al.,
1997). If our hypothesis that CBP is a coactivator with
b-catenin were true, one would predict that E1A would in-
hibit pTOPFLASH expression in our assays. We tested
this prediction, and found that E1A significantly inhibited
transcription in a dose-dependent manner (Fig. 3 A). In
contrast, expression of an E1A mutant that lacks the abil-
ity to interact with CBP (E1A mutCBP; Bannister and
Kouzarides, 1995) even slightly enhanced reporter gene
activity. To further demonstrate the cooperation between
CBP and b-catenin, we carried out transfection assays with
the human colon carcinoma cell line, SW480 (Fig. 3 B). In
these cells, the level of b-catenin is increased as a result of
inactivating mutations in the tumor suppressor gene APC,
leading to constitutive transcriptional activation by endog-
enous b-catenin (Korinek et al., 1997). CBP is also limiting
in SW480, since expression of CBP further increased
pTOPFLASH activity (Fig. 3 B). Expression of E1A or
E1A mutRB, which interacts with CBP like E1A, but is
deficient in binding to the retinoblastoma protein (RB;
Bannister and Kouzarides, 1995), resulted in a three- to
fourfold decrease in reporter activity (Fig. 3 B). In con-
trast, E1A mutCBP did not significantly affect reporter
gene expression. We also tested a dominant negative form
of LEF-1 (dnLEF-1), which lacks b-catenin binding do-
main, and found that dnLEF-1 reduced reporter activity to
an extent similar to E1A or E1A mutRB (Fig. 3 B). These
observations suggest that endogenous CBP is required for
Figure 3. E1A represses
b-catenin–mediated tran-
scriptional activation. A, The
reporter plasmid pTOP-
FLASH (1 mg) was trans-
fected into HeLa cells with
or without 1 mg of pt b-cate-
nin–encoding plasmid. The
expression vector encoding
E1A or E1A mutCBP (100
or 500 ng) were cotrans-
fected as indicated. B,
SW480 cells were cotrans-
fected with 100 ng of the
pTOPFLASH reporter, and
increasing amounts (100 or
400 ng) of CBP expression
plasmid, 5 ng each of the
plasmids encoding E1A WT,
E1A mutRB, or E1A
mutCBP, or 50 ng of dnLEF-1
expression plasmid as indi-
cated. The activity of the
pTOPFLASH reporter in the
absence of exogenous CBP,
E1A, or dnLEF-1 was set at
100%.
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b-catenin–mediated transcriptional activation. The experi-
ments with E1A thus confirm the prior data supporting
the hypothesis that CBP is a coactivator with b-catenin.
The previous finding that dCBP could bind to mouse
LEF-1 in vitro (Waltzer and Bienz, 1998) raised the possi-
bility that CBP might be recruited through the interaction
with TCF/LEF factors, but not through b-catenin. To ana-
lyze the functional importance of the binding of the
bcatR10-C domain to CBP more directly, we performed
transient transfection assays in HeLa cells using the
bcatR10-C domain fused to the DNA-binding domain of
the yeast GAL4 protein (GAL4-bcatR10-C). As previ-
ously reported (Hecht et al., 1999), expression of GAL4-
bcatR10-C fusion was sufficient to activate the pFR-Luc
reporter harboring five GAL4-binding sites (Fig. 4). Coex-
pression of E1A efficiently abrogated the reporter gene
activity. In contrast, little effect was observed with coex-
pression of E1A mutCBP. These results clearly indicate
that b-catenin cooperates with CBP to activate transcrip-
tion.
To examine whether the activation of endogenous tar-
get genes by b-catenin also involves CBP, we analyzed the
effects of E1A on the expression of Wnt target genes in
Xenopus animal cap explants by RT-PCR (Fig. 5). Consis-
tent with the results described above, coexpression of E1A
strongly reduced the expression of siamois and Xnr3 in-
duced by Xwnt-8 (Fig. 5, lane 5 compared with Xwnt-8
alone, lane 3), whereas E1A mutCBP showed a weaker in-
hibition (Fig. 5, lane 4 compared with lane 3). Further-
more, coexpression of CBP overcame the inhibitory effect
of E1A (Fig. 5, lane 6 compared with lane 5). These data
suggest that CBP is required for the activation of Wnt-
responsive genes in Xenopus embryos.
Our results provide compelling evidence that CBP is a
coactivator for b-catenin. In Drosophila, it has been
shown that dCBP negatively regulates Wingless signaling
(Waltzer and Bienz, 1998). However, overexpression of
CBP had no repressive effect on reporter expression in
our assays. Moreover, we could not detect an interaction
between human LEF-1 and the C/H3 domain of CBP us-
ing RRS (data not shown), although the corresponding re-
gion of dCBP was shown to bind to mouse LEF-1 (Waltzer
and Bienz, 1998). It is possible that dCBP functionally dif-
fers from its vertebrate orthologs. In vertebrates, CBP
functions as a transcriptional coactivator through the in-
teraction with b-catenin, whereas dCBP is recruited to a
promoter by dTCF to repress transcription. Alternatively,
CBP may behave as a repressor in the absence of Wnt sig-
naling, but it turns into a coactivator of b-catenin upon sig-
naling.
The mechanism by which CBP stimulates b-catenin–
mediated activation is yet to be established. CBP might
help to recruit the basal transcription machinery. In addi-
tion, CBP was shown to possess intrinsic histone acetyl-
transferase activity (Ogryzko et al., 1996), and to associate
with multiple acetyltransferases, such as P/CAF (Yang et
al., 1996). On the other hand, Groucho has been demon-
strated to directly interact with the histone deacetylase
Rpd3 in Drosophila, suggesting that Groucho-mediated
repression may involve the modulation of local chromatin
structure (Chen et al., 1999). Thus, it remains possible that
the histone acetyltransferase activities are required for re-
modeling chromatin structure, alleviating the repression
by Groucho factors.
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